Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,485 USD | -4,07% | -18,94% | -12,48% |
Vakgebied
Aantal werknemers: 8
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Proprietary Medicinal Products
100,0
%
| 0 | nan % | 6 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 6 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Berman
CEO | Chief Executive Officer | 50 | 01-01-20 |
Fred Grossman
PSD | President | 62 | 17-07-23 |
David Snyder
DFI | Director of Finance/CFO | 63 | 30-03-22 |
Michelle Frazier
LAW | General Counsel | - | 14-06-23 |
Arun Swaminathan
PRN | Corporate Officer/Principal | - | 27-03-23 |
John M. Centanni
LAW | General Counsel | - | 01-03-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wilbur Ross
BRD | Director/Board Member | 85 | 19/12 |
Dov Goldstein
BRD | Director/Board Member | 56 | 14-04-21 |
Hideki Garren
BRD | Director/Board Member | 60 | 01-06-21 |
Dieter Weinand
BRD | Director/Board Member | 63 | 18-08-23 |
Director/Board Member | 65 | 25-05-21 | |
Ann Lee
BRD | Director/Board Member | 62 | 01-06-21 |
Howard Berman
CEO | Chief Executive Officer | 50 | 01-01-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 618 172 | 12 966 956 ( 88,70 %) | 0 | 88,70 % |
Bedrijfsgegevens
Coya Therapeutics, Inc.
5850 San Felipe Street Suite 500
77057, Houston
+
http://www.coyatherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,48% | 98,71 mln. | |
+34,01% | 51,07 mld. | |
+33,84% | 38,86 mld. | |
-8,02% | 38,78 mld. | |
-8,98% | 26,69 mld. | |
+12,56% | 26,35 mld. | |
-19,62% | 19,46 mld. | |
+39,18% | 13,58 mld. | |
+31,47% | 12,46 mld. | |
-3,40% | 11,75 mld. |
- Beurs
- Aandelen
- Koers COYA
- Onderneming Coya Therapeutics, Inc.